Example: Heart Attack

Clinical Trials on Hemifacial Spasm

Total 20 results

  • NCT05103202
    Completed
    Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin
    Conditions: Cervical Dystonia, Blepharospasm, Limb Dystonia, Hemifacial Spasm, Spasticity, Muscle, Fragments of Torsion Dystonia
  • NCT04621578
    Completed
    Transcutaneous Electrical Acupoint Stimulation on Postoperative Dizziness in Hemifacial Spasm Patients
    Conditions: Transcutaneous Electrical Acupoint Stimulation, Hemifacial Spasm, Dizziness
  • NCT04645277
    Recruiting
    Magnetic Resonance Imaging Study on Patients With Hemifacial Spasm
    Conditions: Hemifacial Spasm, Magnetic Resonance Imaging
  • NCT04589364
    Not yet recruiting
    Study of Abobotulinum Toxin Versus Neubotulinum Toxin Injection For Hemifacial Spasm in Thai Patients
    Conditions: Hemifacial Spasm
  • NCT04474977
    Not yet recruiting
    Microvascular Decompressive Surgery for Hemifacial Spasm
    Conditions: Hemifacial Spasm
  • NCT00276315
    Completed
    Assessment of Effectiveness and Safety of Dysport® for the Treatment of Hemifacial Spasm
    Conditions: Hemifacial Spasm
  • NCT00210431
    Completed
    Post Marketing Surveillance Study of Dysport
    Conditions: Blepharospasm, Hemifacial Spasm, Cervical Dystonia, Spasmodic Torticollis, Cerebral Palsy, Muscle Spasticity, Cerebrovascular Accident, Equinus Deformity, Facial Hyperdynamic Lines
  • NCT03508882
    Completed
    Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm
    Conditions: Blepharospasm, Hemifacial Spasm, Botulinum Toxins, Type A
  • NCT02761096
    Completed
    Effect of Acupuncture on Inflammation and Immune Function After Craniotomy
    Conditions: Unruptured Cerebral Aneurysm, Hemifacial Spasm, Brain Tumor
  • NCT03390803
    Completed
    Effect of Hemifacial Spasm on Intraocular Pressure Measurement
    Conditions: Hemifacial Spasm, Intraocular Pressure
  • NCT03306940
    Unknown status
    Botulinum Toxin A in the Treatment of Hemifacial Spasm
    Conditions: Hemifacial Spasm
  • NCT01932255
    Withdrawn
    CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap
    Conditions: Cranial Nerve Diseases, Facial Neuralgia, Trigeminal Neuralgia, Hemifacial Spasm
  • NCT01598961
    Completed
    Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression Surgery
    Conditions: Hemifacial Spasm, Microvascular Decompression, Lateral Spread Response Monitoring
  • NCT01613781
    Completed
    Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression Surgery
    Conditions: Hemifacial Spasm, Microvascular Decompression, Neuromuscular Blockade
  • NCT01728428
    Completed
    A Multicenter, Observational Study to Evaluate Clinical Manifestation, Diagnosis and Treatment of Primary Hemifacial Spasm in Chinese Patients
    Conditions: Hemifacial Spasm
  • NCT01726725
    Unknown status
    Hemifacial Spasm and Desflurane
    Conditions: Hemifacial Spasm
  • NCT01564979
    Unknown status
    Effect on Tear Functions of Pretarsal and Preseptal Techniques of Botulinum Toxin Type A Injection in Hemifacial Spasm
    Conditions: Hemifacial Spasm
  • NCT01546805
    Unknown status
    Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial Spasm
    Conditions: Blepharospasm, Hemifacial Spasm
  • NCT01271634
    Unknown status
    Observe Abnormal Potential From the Offending Vessel to the Facial Muscles of HFS Patients
    Conditions: Hemifacial Spasm
  • NCT01168388
    Completed
    Movement Disorder Survey in East China
    Conditions: Primary Dystonia, Hemifacial Spasm

Medical Conditions

Sponsors and Collaborators

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations